Silence Therapeutics | SLN - Gross Profit On Sales

Stock Price
5.50
Daily Change
0.08 1.48%
Monthly
7.63%
Yearly
16.53%
Q1 Forecast
4.90

Silence Therapeutics reported $-1.63M in Gross Profit on Sales for its fiscal quarter ending in September of 2024.





Gross Profit On Sales Change Date
AstraZeneca USD 12.39B 5M Dec/2025
Autolus Therapeutics Ltd USD -7.45M 3.93M Sep/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Novartis USD 10.82B 695M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Silence Therapeutics USD -1.63M 408K Sep/2024